More on BCRX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.2 Score)
- Holders
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (8/4/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BioCryst Pharma (NQ:BCRX)
Delayed: 8.48 -0.02 (0.24%)
Prev. Close $8.50  
Open$8.40 
52 Wk High$10.98 
52 Wk Low$1.63 
Day High$8.51 
Day Low$8.31 
P/E N/A  
EPS$-0.68 
Volume3,473,695 

Friends, Peers and Foes (?): ATXS, ACAD, XENE, BIIB, GILD (more...)

Mar 4, 2026 07:00 AM BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 3, 2026 04:41 PM Form 4 BIOCRYST PHARMACEUTICALS For: Feb 27 Filed by: Milne Jill C.
Mar 3, 2026 04:39 PM Form 4 BIOCRYST PHARMACEUTICALS For: Feb 27 Filed by: Stonehouse Jon P
Mar 3, 2026 04:36 PM Form 4 BIOCRYST PHARMACEUTICALS For: Feb 27 Filed by: MILANO VINCENT
Mar 3, 2026 04:33 PM Form 4 BIOCRYST PHARMACEUTICALS For: Feb 27 Filed by: Frank Steven
Mar 3, 2026 04:29 PM Form 4 BIOCRYST PHARMACEUTICALS For: Feb 27 Filed by: McKee Amy E
Mar 2, 2026 03:16 PM Form 144 BIOCRYST PHARMACEUTICALS Filed by: Stonehouse Jon P
Feb 26, 2026 04:06 PM Form 10-K BIOCRYST PHARMACEUTICALS For: Dec 31
Feb 26, 2026 01:30 PM TD Cowen Reiterates Buy Rating on BioCryst Pharma (BCRX)
Feb 26, 2026 07:58 AM BioCryst Pharma (BCRX) Tops Q4 EPS by 108c; offers outlook
View All Articles

Entities mentioned with BCRX

View All Entities